INTRODUCTION
Hearing loss is often referred to as the invisible handicap. It is debilitating, isolating, and is a frequently occurring abnormality present at birth. If detection is delayed or denied, significant speech, language, social, and emotional delays may result. 2, 5 The National Institutes of Health (NIH) Consensus Statement on Early Identification of Hearing Impairment in Infants and Young Children (1993) and the Joint Committee on Infant Hearing 1994 Position Statement endorse the goal of universal detection of hearing loss and early intervention for hearing loss. 3, 4 Unfortunately, early intervention is not enough. Successful tracking and follow-up measures must also be in place. The success of any tracking system is dependent upon consistent use, measurement of the statistics, and feedback to the involved personnel.
The purpose of this paper is to discuss one method for data collection, tracking, and successful follow-up management of all newborns in 46 sites within 11 states.
Although there are variances with protocols within newborn hearing screening programs, there is a common goal: to identify hearing loss early and initiate intervention in a timely manner. Recent developments contributing to a wider recognition of the importance of Newborn Hearing Screening include the American Academy of Pediatrics (AAP) endorsement of universal screening, increased state legislation efforts, and Public Law 106-113, 1 which provides funding for hearing tests. Technological advances have made newborn hearing screening simple and effective. However, successful follow-up of neonates with abnormal or suspect tests has not been established in many screening programs. The AAP's recommendation of 5% or less being lost in follow-up, which in the past was unattainable, 2 should be the standard.
PROGRAM OVERVIEW
Pediatrix Medical Group began newborn hearing screening programs in hospitals in 1994. By December 1999, 46 sites within 11 states had newborn hearing screening programs in place. Those 11 states were subdivided into five regions: Atlantic (FL, SC), Central (NJ, PA, OH, VA), Mountain (CO), Pacific (CA, NV, WA), and South Central (TX). More than 66,000 babies were screened for hearing loss in 1999 with more than 120,000 anticipated to be screened during 2000.
Automated auditory brainstem response technology (ALGO newborn hearing screener) has been used by Pediatrix Medical Group for hearing screenings. This automated screening equipment allows both clinical and non-clinical personnel to conduct screening. Each technician completes (1) an in-service by the program educator, (2) a written post-test, (3) a competency checklist, and (4) certification before performing hearing screens independently.
The program's protocol specifies that hearing screens are performed prior to discharge from the hospital nursery. Babies who do not``pass'' the initial screen (refer) are re-screened with the same device prior to discharge in order to reduce the number of infants requiring outpatient testing. If an infant receives a``refer'' result on the hearing screen prior to hospital discharge, a notification is sent to the primary care physician, parent(s), and the Retrospective hearing screening data were analyzed on 66,292 newborns to assess factors which contribute to overall program success, especially those related to tracking and follow -up of positive initial hearing screens. Newborn hearing screens were performed in 46 sites within five regions utilizing automated auditory brainstem response ( AABR ) technology. Pediatrix Medical Group managed all 46 sites and tracked all positive screens under the direction of the national program director. One hundred and fourteen newborns were confirmed with hearing loss, with 60% exhibiting no known risk factors. The five regions collectively yielded a final refer rate of 1.01% over a 1 -year period, whereas two of the five regions boasted capture rates of 98%. Fifty percent of the confirmed hearing losses was bilateral in nature. Several key factors were noted to have a positive impact on the overall success of the program as related to followup. This paper demonstrates that tracking and follow -up can be successful if program management and implementation are considered when establishing a newborn hearing screening program. The protocol presented can be viewed as a model for existing programs by those who are interested in overcoming challenges related to follow -up and can ensure program success. Journal of Perinatology 2000; 20:S137 ± S141.
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audiologist responsible for conducting follow-up assessment and diagnosis.
A site coordinator oversees each of the hearing screening programs and is responsible for downloading the data from the ALGO DataBook (software package) once per month. The coordinator is responsible for monitoring quality indicators obtained from the screening program. The coordinator calls the parents/ guardian of infants who``referred'' to monitor the ongoing progress, ensuring timely diagnosis and intervention. Ongoing communication between the site coordinator and the central data manager allows additional continued monitoring of outcomes and quality improvement. Data on the number of infants screened, the number of abnormal tests, and referral patterns are kept in a computer database that allows detailed monthly analysis. The monthly reports provide feedback to individual sites that lead to identification of strengths and weaknesses.
Community education is also of major importance. It is a vital component for successful screening and often overlooked when creating universal newborn hearing screening programs. Educating key professionals and creating community awareness empowers pertinent individuals to make better decisions related to newborn hearing screening. A physician sponsors each of the hearing screening programs. The physician is instrumental in educating the medical community, hospital staff, and public about newborn hearing screening and helps facilitate support for screening from the legislation. Additionally, the physician reviews the hearing screening results, ensuring higher quality. Education also serves as a vehicle for facilitating follow-up for children who fail their hearing screen before hospital discharge. Educational efforts can have positive long-term implications as well by informing parents and physicians about late onset and progressive hearing loss. Public awareness to encourage involvement by many different people such as physicians, parents, nurses, and auxiliary personnel is accomplished by participation in health fairs, organized hospital in-services, and educational literature provided. Hospital public service announcements and press releases regarding the newborn hearing screening program are generated to raise awareness of the incidence of hearing impairment and the positive impact that early identification and intervention of hearing loss can make in a child's life.
PROGRAM STRUCTURE Screeners
Clinical and non-clinical personnel perform the AABR hearing screens. The screening staff are: (1) given equipment training; (2) certified in newborn hearing screening; (3) instructed in the proper usage of the hearing screening forms and procedures; (4) trained regarding parent education; and (5) trained in referral tracking and management. Hearing screening is performed in a timely fashion with coverage 7 d/wk, including weekends and holidays.
Equipment AABR technology, specifically the ALGO newborn hearing screener, is used for initial and follow-up screenings. The ALGO newborn hearing screener works by generating soft broadband clicks delivered from specially designed earphones, which are placed over the baby's ears. Sensors placed on the baby's skin read the auditory brainstem response generated by the clicks. The baby's auditory brainstem response is compared to normative data stored within the screener and a``pass'' or``refer'' result is automatically produced.
Screening Protocol
All AABR newborn hearing screens are performed by dedicated screeners either in the nursery or at the mother's bedside. Evaluations take place before discharge and each neonate must pass the hearing screen in both ears before being given a``pass'' result. When a hearing screen is performed in the neonatal intensive care unit, the infant is at least 34 weeks of gestation and stable. Whenever the baby does not``pass'' the hearing screen, a second AABR is performed before discharge. If a second``refer'' result is obtained, every effort is made to schedule the infant for either an outpatient AABR screen within 2 weeks at the hospital site or with an audiologist for diagnostic testing. If an appointment cannot be scheduled before discharge, the infant is tracked by the site coordinator and scheduled for follow-up testing, whenever possible.
Data Management and Tracking
The data for all 46 sites in 1999 were managed under the supervision and direction of one central data manager. All data from the newborn hearing screener are downloaded onto a floppy disk once a month and sent electronically to the data manager. Each infant referred for outpatient testing is tracked by the site coordinator through with the data manager to verify that proper follow-up has occurred and intervention has been obtained when necessary. Every effort is made to make an appointment with the community audiologist prior to discharge for the infant who does not pass the newborn hearing screen. The site coordinator contacts the parent(s) through telephone/letter to ensure that the infant has attended the scheduled follow-up testing appointment. Consent is obtained from parents for release of information regarding the follow-up testing. This allows the program to measure the true-positive and false-positive outcomes of each hearing screening program. An infant is considered``lost'' after 
RESULTS
Between 1994 and 1999, 46 hearing screening programs were initiated by Pediatrix Medical Group. At least 50% of the programs reported was universal. In 1998, approximately 27,000 babies were screened for possible hearing loss, with a final refer rate of 2%. In 1999, 66,292 babies were screened; the number of babies screened more than doubled and the overall final refer rate improved to 1%. Table 1 reflects the national statistics for 1999. Although more hearing screens were performed in 1999 than any other prior year, the final refer rate remained extremely low and well within the guidelines set forth by the AAP. 2 Additionally, the prevalence of newborn hearing loss has been consistently reported in the literature to range from 1.5 to 6 per 1000 live births. 6 ± 8 The incidence of hearing loss among the 46 sites discussed in this paper ranged from 1.4 to 2.3 per 1000 live births.
As a result of the hearing screening programs, 114 infants were identified with hearing loss in 1999. Figure 1 and Table 2 provide information regarding bilateral unilateral hearing loss. Fifty percent was identified as bilateral hearing loss, whereas there was a higher incidence of left ear unilateral hearing loss (29%) versus right ear unilateral hearing loss (21%).
DISCUSSION
The most powerful argument for universal newborn hearing screening is that the average age of diagnosis of hearing loss in children who are not screened at birth is 2 years of age. 9, 10 This is not acceptable, especially when studies show significantly improved language development in association with early identification of hearing loss and intervention. 5 Early identification is not only a reasonable goal, but is achievable. Newer technology makes universal newborn hearing screening effective and efficient.
There were trends identified when reviewing the data collected from the 46 program sites. The South Central and Mountain regions demonstrated very high capture rates of 98%. Texas has promoted universal newborn hearing screening with legislation requiring all hospitals with more than 1000 births to screen all newborns for hearing loss prior to discharge by May 1, 2000 with the smaller birthing facilities being required to comply with screening guidelines by April 1, 2001 . At the other end of the spectrum are the states of Washington, Nevada, and California. While California Ð the largest birthing state in the U.S. Ð introduced the Governor's initiative, which takes effect in 2001, the initiative requires screening 12 infants with hearing loss have clinical profiles that overlap significantly with newborns who have normal hearing. Of the 114 infants confirmed with hearing loss, only 40% was identified with risks noted to contribute to hearing loss. Therefore, 60% of newborns with hearing loss had no risk factors, and most of the newborns who presented with high-risk factors did not demonstrate hearing loss 13 ± 15 (see Table 3 ).
KEYS TO SUCCESSFUL SCREENING, TRACKING, AND FOLLOW-UP
There are several key components that contribute to the success of the entire screening program that includes follow-up of those infants who do not pass the initial hearing screen. It begins with equipment selection and effective program management and ends only when intervention is achieved for the positive screen that results in a child diagnosed with hearing loss. Consistently low refer rates, high capture rates, open communication between all program personnel, and community education all contribute significantly to overall program success, but data management that allows easy access to outcomes is imperative.
A site coordinator, who is organized, detail-oriented, and an effective communicator is vital to the screening program's success. Data management will not work unless the site coordinator: (1) communicates with the data manager for immediate data input into the data management system; (2) tracks the infants who have failed the screen when they are discharged from the hospital; and (3) effectively communicates with those medical personnel involved in the follow-up of those infants identified with possible hearing loss. It is not the type of data management system that is important, but rather the fact that it is updated and analyzed monthly, and that its statistics are measured.
CONCLUSION
The data presented here show that effective hearing screening and appropriate follow-up of neonates identified as having abnormal screening are possible and important. The model we report should lead to even more universal screening of neonates and a further reduction in unnecessary delays in intervention. 
